Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer
- 26 October 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 231 (6), 681-692
- https://doi.org/10.1016/j.jamcollsurg.2020.08.775
Abstract
Background Trimodality therapy with neoadjuvant chemoradiation (nCRT), surgery, and adjuvant chemotherapy is the standard treatment for locally advanced rectal cancer. There is evidence that surgery can be deferred in patients with complete response (CR) to nCRT, a strategy termed “watch-and-wait” (WW). We compare WW to surgery in patients with CR to nCRT. Study Design We reviewed records of patients treated with nCRT for nonmetastatic rectal cancer at our institution. Complete endoscopic response (CER) was defined as negative digital rectal exam and negative endoscopy at the end of neoadjuvant therapy (NAT). Clinical complete response (cCR) was defined as CER with negative rectal MRI. Patients with CER refusing surgery were offered WW, which included strict surveillance with digital rectal exam and endoscopy. Results From January 2015 through February 2019, 465 patients completed nCRT; 406 patients had response assessment, of which 95 (23%) had CER. Of these patients, 53 patients underwent WW and 42 patients had surgery. Median follow-up was 35 months. In the WW group, 3-year freedom from local regrowth was 85%. In the surgical and WW groups, 3-year overall survival, rectal cancer-specific survival, and freedom from nonregrowth recurrence were 100% vs 88% (p = 0.03), 100% vs 95% (p = 0.16), and 92% vs 85% (p = 0.36), respectively. Of the 6 WW patients with local regrowth, 5 (83%) eventually developed distant recurrence. Conclusions WW in lieu of surgery appears to be a safe and feasible treatment approach for patients achieving CR to nCRT. Careful evaluation to confirm cCR after nCRT is valuable in selecting patients for WW.Keywords
This publication has 30 references indexed in Scilit:
- Nonoperative Management of Rectal CancerHematology/Oncology Clinics of North America, 2015
- Practice Parameters for the Management of Rectal Cancer (Revised)Diseases of the Colon & Rectum, 2013
- Pre-operative chemoradiation for non-metastatic locally advanced rectal cancerEmergencias, 2012
- Sociodemographic Characteristics of Members of a Large, Integrated Health Care System: Comparison with US Census Bureau DataThe Permanente Journal, 2012
- Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for StandardizationDiseases of the Colon & Rectum, 2010
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataThe Lancet Oncology, 2010
- Volume–outcome analysis of colorectal cancer-related outcomesBritish Journal of Surgery, 2010
- Postoperative Complications Following Surgery for Rectal CancerAnnals of Surgery, 2010
- Patterns of Failure and Survival for Nonoperative Treatment of Stage c0 Distal Rectal Cancer Following Neoadjuvant Chemoradiation TherapyJournal of Gastrointestinal Surgery, 2006
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004